Home›Stock Screener›Rekvina Laboratories›Quarterly Results

Rekvina Laboratories Quarterly Results

Latest Quarter Net Profit
₹0 Cr
QSept 2026
Quarterly Results

Rekvina Laboratories quarterly results. In Sept 2026, Rekvina Laboratories (VINRKLB) reported revenue ₹4 Cr and net profit ₹0 Cr. For annual financials, live price and key ratios, visit VINRKLB stock price BSE.

VINRKLB Quarterly Results — Revenue, Profit & EPS Highlights

Rekvina Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore VINRKLB price movement history to track price trends across different timeframes.

  • Revenue of ₹4 Cr in Sept 2026 (+300.0% vs Jun 2026)
  • Operating Margin of 8.0% in Sept 2026 (+26.0pp vs Jun 2026)
  • Earnings Per Share of ₹0.09 in Sept 2026 (+145.0% vs Jun 2026)

Rekvina Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS

VINRKLB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Jun 2026 Sept 2025 QoQ YoY
Revenue (₹ Cr) 4 1 0 300.0% -
Net Profit (₹ Cr) 0 0 0 - -
EBITDA (₹ Cr) 0 0 0 - -
EPS (₹) 0.09 -0.20 -0.06 - -
Operating Margin (%) 8.0% -18.0% -15.0% - -

VINRKLB Share Price Trend — 1-Year Movement Across Quarterly Results

Rekvina Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View VINRKLB 52-week performance for the annual high/low range and current price position.

Profitability Ratios

Operating Margin 8.0%

Balance Sheet Highlights

Total Assets ₹1 Cr
Total Equity ₹-1 Cr
Current Assets ₹ Cr
Current Liabilities ₹0 Cr

Cash Flow Analysis

Operating Cash Flow ₹-1 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹1 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹80.17
Exchange BSE
Last Updated Nov 20, 2026

VINRKLB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Rekvina Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1884.9 16,617 1,995 +10.6% - 12.0% 227.1
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11180.5 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4689.5 4,111 364 +27.7% +42.2% 8.9% 407.4
Apollo Hospitals
Sept 2026
₹132,281.88 Cr 9200.0 7,673 660 +15.2% - 8.6% 209.9
Laurus Labs
Sept 2026
₹125,946.78 Cr 2294.6 2,219 436 +21.7% - 19.6% 280.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores